Predicting response and survival in chemotherapy-treated triple-negative breast cancer
- Citation:
- Br J Cancer vol 111 (8) 1532-1541
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- This work was presented, in part, as an oral communication at the ASCO 2012 annual meeting (Abstract #10500)
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 4
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U24CA196171 , U01 CA114722-01, P50-CA58223-09A1, U10 CA033601, R01 CA138255, U10 CA180821, P30 CA016086, U01 CA114722, P50 CA058223, R01-CA138255, U10-CA33601, U10 CA180882, U24 CA196171, U10 CA180838
- Corr. Author:
- Authors:
- A Prat A Lluch J Albanell W T Barry C Fan J I Chacón J S Parker L Calvo A Plazaola A Arcusa M A Seguí-Palmer O Burgues N Ribelles A Rodriguez-Lescure A Guerrero M Ruiz-Borrego B Munarriz J A López B Adamo M C U Cheang Y Li Z Hu M L Gulley M J Vidal B N Pitcher M C Liu M L Citron M J Ellis E Mardis T Vickery C A Hudis E P Winer L A Carey R Caballero E Carrasco M Martín C M Perou E Alba
- Networks:
- Study
- CALGB-159905
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-9741
- Phases:
- N/A, 3
- Keywords:
- breast cancer, genomics, subtypes, intrinsic, basal like, chemotherapy, neoadjuvant